How phenotype guides management of the neuroendocrine carcinomas of the larynx

J Laryngol Otol. 2018 Jul;132(7):568-574. doi: 10.1017/S0022215118000968. Epub 2018 Jun 18.

Abstract

Objective: This review aimed to critically analyse data pertaining to the clinical presentation and treatment of neuroendocrine carcinomas of the larynx.

Method: A PubMed search was performed using the term 'neuroendocrine carcinoma'. English-language articles on neuroendocrine carcinoma of the larynx were reviewed in detail.Results and conclusionWhile many historical classifications have been proposed, in contemporary practice these tumours are sub-classified into four subtypes: carcinoid, atypical carcinoid, small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma. These tumours exhibit a wide range of biological behaviour, ranging from the extremely aggressive nature of small and large cell neuroendocrine carcinomas, which usually have a fatal prognosis, to the less aggressive course of carcinoid tumours. In small and large cell neuroendocrine carcinomas, a combination of irradiation and chemotherapy is indicated, while carcinoid and atypical carcinoid tumour management entails conservation surgery.

Keywords: Carcinoid Tumors; Laryngeal Cancer; Larynx; Neuroendocrine Carcinoma; Neuroendocrine Tumors.

Publication types

  • Review

MeSH terms

  • Antineoplastic Protocols
  • Carcinoid Tumor / genetics
  • Carcinoid Tumor / pathology
  • Carcinoid Tumor / therapy
  • Carcinoma, Neuroendocrine / genetics*
  • Carcinoma, Neuroendocrine / pathology
  • Carcinoma, Neuroendocrine / therapy*
  • Carcinoma, Small Cell / genetics
  • Carcinoma, Small Cell / pathology
  • Carcinoma, Small Cell / therapy
  • Conservative Treatment / methods
  • Humans
  • Laryngeal Neoplasms / genetics*
  • Laryngeal Neoplasms / pathology
  • Laryngeal Neoplasms / therapy*
  • Larynx / pathology
  • Larynx / surgery
  • Phenotype*
  • Prognosis